FATE THERAPEUTICS INC (FATE) › Operating IncomeFATE THERAPEUTICS INC (FATE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$13.29M2012: -$13.56M2013: -$17.68M2014: -$24.90M2015: -$27.78M2016: -$31.96M2017: -$42.12M2018: -$67.09M2019: -$100.73M2020: -$128.09M2021: -$216.99M2022: -$308.39M2023: -$190.51M2024: -$210.28M2025: -$147.70M-$147.70M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$147.70M+29.8%2024-$210.28M-10.4%2023-$190.51M+38.2%2022-$308.39M-42.1%2021-$216.99M-69.4%2020-$128.09M-27.2%2019-$100.73M-50.1%2018-$67.09M-59.3%2017-$42.12M-31.8%2016-$31.96M-15.0%2015-$27.78M-11.6%2014-$24.90M-40.9%2013-$17.68M-30.4%2012-$13.56M-2.0%2011-$13.29M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share